-
The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland
Mar 10, 2025, 14:00 PM -
Identifying Risk Factors of Flare(s) in Patients With SLE After Glucocorticoids (GC) Withdrawal (<7.5mg) across 1.5 Years
Mar 10, 2025, 14:00 PM -
Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies
Mar 10, 2025, 14:00 PM -
Conceptual Framework for a De Novo Cost-effectiveness Model in Glycogen Storage Disease Type Ia (GSDIa)
Mar 10, 2025, 14:00 PM -
Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Use of Health Technology Assessments in Specialty Drug Coverage Decisions by U.S. Commercial Health Plans
Mar 10, 2025, 14:00 PM -
An Economic Model to Evaluate the Impact of Formulary Tier Increases for Apixaban on the Incidence and Cost of Clinical Events in Patients with Non-Valvular Atrial Fibrillation in the United States
Mar 10, 2025, 14:00 PM -
Cost Comparison of Osimertinib Plus Chemotherapy Versus Amivantamab Plus Lazertinib for the First-Line Treatment of Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC
Mar 10, 2025, 14:00 PM -
Hepatitis C Elimination via Subscription-Based Payment Models: A Synthetic Control Study from Washington and Louisiana
Mar 10, 2025, 14:00 PM -
Real-world Impact of Semaglutide, Liraglutide, and Tirzepatide on Weight Loss and Cardiometabolic Lab Measures: A Look into Drug Persistence and Reasons for Discontinuation (r/dc)
Mar 10, 2025, 14:00 PM -
Training and Validation of CARAaiTM: A Multi LLM Platform and Data Model to Address Oncology-Specific Challenges in Clinical Data Extraction
Mar 10, 2025, 14:00 PM -
Cost-Utility analysis of Dinutuximab Beta in Treating High-Risk Neuroblastoma: A Partitioned Survival Model Using R programming Language
Mar 10, 2025, 14:00 PM -
Challenges for PAIC in Rare Diseases: Results of a Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Estimating the Burden of Illness and Healthcare Costs Among Incident Catheter Users: A Comparison of Intermittent and Indwelling Catheter Cohorts Across Spinal Cord Injury, Multiple Sclerosis, Spina Bifida, and Benign Prostatic Hyperplasia in the US
Mar 10, 2025, 14:00 PM -
Comparing Chemotherapy, Monotherapy, and Combination Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer Progression-Free Survival and Overall Survival: Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated With First-Line Platinum-Based Chemotherapy (PBC) and =2 Subsequent Lines of Therapy in the United States
Mar 10, 2025, 14:00 PM -
Burden of Administration: Belamaf Based Combinations (BVd, BPd) Versus Carfilzomib Based Combinations (IsaKd, DKd, Kd)
Mar 10, 2025, 14:00 PM -
Practical Application of the ICER-developed Clinical Trial Diversity Rating Tool
Mar 10, 2025, 14:00 PM -
Evaluation of Epidemiological Disease Burden of Endometriosis Based on Routinely Collected Health Data Between 2010 and 2019
Mar 10, 2025, 14:00 PM -
Indirect Costs Associated With Neovascular Age-Related Macular Degeneration (nAMD) in Colombia
Mar 10, 2025, 14:00 PM
